Published in Hepatitis Weekly, December 17th, 2001
Given the expense of interferon therapy and its mode of action, "Compliance with diagnostic procedures and, even more important, with medical treatment is obviously critical to minimize the rate of dropouts and to maximize cost efficiency," M.R. Kraus, lead investigator of a recent study, said of patients offered interferon therapy for chronic hepatitis C.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly